Fragment-Based Drug Discovery Market Is Likely to Witness a Growth at a Steady CAGR of 14.4% from 2015 to 2023
The global fragment-based drug discovery market is anticipated to experience some intense growth in coming years due to the emergence of leading players in the market, states Transparency Market Research (TMR) in its latest research report. According to a recent news report by one of the significant company in the market Astex Pharmaceuticals which has a partnership with Newcastle University, and Cancer Research UK has extended its tie-up for three more years in order to work upon and develop some...
View full press release